Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NU SKIN ENTERPRISES, INC.NUS · Entity 6223 | Chief Scientific Officer | March 01, 2023 | March 03, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NU SKIN ENTERPRISES, INC.
Report date March 01, 2023 · Filed March 03, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 21,234 |
Ending reported balance
After 2023-03-02 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2023-03-01 · Exercise / conversion · Acquired 68,485 · Balance 89,719 Row 2 · 2023-03-01 · Sale · Disposed 68,485 · Balance 21,234 F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.89 to $40.80, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Row 3 · 2023-03-02 · Exercise / conversion · Acquired 600 · Balance 21,834 Row 4 · 2023-03-02 · Exercise / conversion · Acquired 24,400 · Balance 46,234 Row 5 · 2023-03-02 · Sale · Disposed 25,000 · Balance 21,234 F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.31 to $41.21, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $30.63 · Expires 2023-03-02 | Direct | 0 |
Reported balance
After 2023-03-01 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2023-03-01 · Exercise / conversion · Disposed 42,485 · Balance 0 F4: Currently exercisable in full. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $30.63 · Expires 2023-03-02 | Direct | 600 |
Reported balance
After 2023-03-01 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2023-03-01 · Exercise / conversion · Disposed 26,000 · Balance 600 F4: Currently exercisable in full. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $30.63 · Expires 2023-03-02 | Direct | 0 |
Reported balance
After 2023-03-02 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2023-03-02 · Exercise / conversion · Disposed 600 · Balance 0 F4: Currently exercisable in full. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $30.45 · Expires 2027-02-15 | Direct | 59,410 |
Reported balance
After 2023-03-02 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2023-03-02 · Exercise / conversion · Disposed 24,400 · Balance 59,410 F4: Currently exercisable in full. |
| Class A Common StockSEC Table I · non-derivative | IndirectHeld in irrevocable family trust | 78,068 |
Reported balance
Holding disclosure · report date 2023-03-01 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 78,068 F3: This report should not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.89 to $40.80, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.31 to $41.21, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.
F3: This report should not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
F4: Currently exercisable in full.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 02, 2023 Filed Mar 3, 2023 23:32 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 24,400 | $0.00 Strike: $30.45 | $0.00 |
DisclosureSEC source: 0001062993-23-005953 · form4.xml · derivative · entry 10 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,410 Underlying: Class A Common Stock · 24,400 shares Expires 2027-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Currently exercisable in full. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 23:32 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 600 | $0.00 Strike: $30.63 | $0.00 |
DisclosureSEC source: 0001062993-23-005953 · form4.xml · derivative · entry 9 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 600 shares Expires 2023-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Currently exercisable in full. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 23:32 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | SaleClass A Common Stock | 25,000 | $40.77 | $1,019,250.00 |
DisclosureSEC source: 0001062993-23-005953 · form4.xml · nonDerivative · entry 5 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,234 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.31 to $41.21, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 23:32 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionClass A Common Stock | 24,400 | $30.45 | $742,980.00 |
DisclosureSEC source: 0001062993-23-005953 · form4.xml · nonDerivative · entry 4 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,234 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 23:32 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionClass A Common Stock | 600 | $30.63 | $18,378.00 |
DisclosureSEC source: 0001062993-23-005953 · form4.xml · nonDerivative · entry 3 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,834 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 23:32 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 26,000 | $0.00 Strike: $30.63 | $0.00 |
DisclosureSEC source: 0001062993-23-005953 · form4.xml · derivative · entry 8 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600 Underlying: Class A Common Stock · 26,000 shares Expires 2023-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Currently exercisable in full. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 23:32 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 42,485 | $0.00 Strike: $30.63 | $0.00 |
DisclosureSEC source: 0001062993-23-005953 · form4.xml · derivative · entry 7 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 42,485 shares Expires 2023-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Currently exercisable in full. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 23:32 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | SaleClass A Common Stock | 68,485 | $40.44 | $2,769,533.40 |
DisclosureSEC source: 0001062993-23-005953 · form4.xml · nonDerivative · entry 2 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,234 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.89 to $40.80, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 23:32 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionClass A Common Stock | 68,485 | $30.63 | $2,097,695.55 |
DisclosureSEC source: 0001062993-23-005953 · form4.xml · nonDerivative · entry 1 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,719 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2023 Filed Feb 16, 2023 23:14 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Tax withholdingClass A Common Stock | 1,981 | $45.38 | $89,897.78 |
DisclosureSEC source: 0001062993-23-003827 · form4.xml · nonDerivative · entry 1 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,234 F1 · shares: Shares withheld to cover tax withholding obligations related to the vesting of previously granted restricted stock units. Read SEC document |
| February 14, 2023 Filed Feb 16, 2023 23:14 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | GrantEmployee Stock Option (Right to Buy) · Derivative | 17,692 | $0.00 Strike: $30.45 | $0.00 |
DisclosureSEC source: 0001062993-23-003827 · form4.xml · derivative · entry 3 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,810 Underlying: Class A Common Stock · 17,692 shares Expires 2027-02-15 F3 · shares: On February 15, 2020, the reporting person was granted stock options to purchase shares of Class A Common Stock, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 14, 2023, the performance criteria were met, resulting in the vesting of the amount shown above. Read SEC document |
| December 18, 2022 Filed Dec 20, 2022 22:15 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 6,800 | $0.00 Strike: $37.58 | $0.00 |
DisclosureSEC source: 0001062993-22-024235 · form4.xml · derivative · entry 4 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 6,800 shares Expires 2022-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: In accordance with the terms of the Issuer's stock incentive plans, these options were automatically net exercised immediately prior to their expiration. F5 · derivative.exercise_date: Currently exercisable in full. Read SEC document |
| December 18, 2022 Filed Dec 20, 2022 22:15 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Tax withholdingClass A Common Stock | 6,542 | $40.33 | $263,838.86 |
DisclosureSEC source: 0001062993-22-024235 · form4.xml · nonDerivative · entry 2 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,215 F2 · shares: In accordance with the terms of the Issuer's stock incentive plans, these shares were withheld by the Issuer to cover the option exercise price and tax withholding obligations related to the automatic net exercise of options immediately prior to their expiration. Read SEC document |
| December 18, 2022 Filed Dec 20, 2022 22:15 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionClass A Common Stock | 6,800 | $37.58 | $255,544.00 |
DisclosureSEC source: 0001062993-22-024235 · form4.xml · nonDerivative · entry 1 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,757 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: In accordance with the terms of the Issuer's stock incentive plans, these shares were acquired from the automatic net exercise of options immediately prior to their expiration. Read SEC document |
| June 01, 2022 Filed Jun 2, 2022 22:15 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 16,000 | $0.00 Strike: $30.63 | $0.00 |
DisclosureSEC source: 0001062993-22-014216 · form4.xml · derivative · entry 5 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,600 Underlying: Class A Common Stock · 16,000 shares Expires 2023-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Currently exercisable in full. Read SEC document |
| June 01, 2022 Filed Jun 2, 2022 22:15 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | SaleClass A Common Stock | 7,025 | $46.97 | $329,964.25 |
DisclosureSEC source: 0001062993-22-014216 · form4.xml · nonDerivative · entry 3 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,957 F1 · shares: Sale pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.81 to $47.25, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| June 01, 2022 Filed Jun 2, 2022 22:15 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | SaleClass A Common Stock | 8,975 | $46.25 | $415,093.75 |
DisclosureSEC source: 0001062993-22-014216 · form4.xml · nonDerivative · entry 2 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,982 F1 · shares: Sale pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.77 to $46.75, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| June 01, 2022 Filed Jun 2, 2022 22:15 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionClass A Common Stock | 16,000 | $30.63 | $490,080.00 |
DisclosureSEC source: 0001062993-22-014216 · form4.xml · nonDerivative · entry 1 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,957 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2022 Filed Mar 3, 2022 21:22 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,423 | $0.00 Strike: $30.63 | $0.00 |
DisclosureSEC source: 0001062993-22-006655 · form4.xml · derivative · entry 5 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,600 Underlying: Class A Common Stock · 3,423 shares Expires 2023-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Currently exercisable in full. Read SEC document |
| March 02, 2022 Filed Mar 3, 2022 21:22 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | SaleClass A Common Stock | 923 | $46.53 | $42,947.19 |
DisclosureSEC source: 0001062993-22-006655 · form4.xml · nonDerivative · entry 3 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,957 F1 · shares: Sale pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.35 to $46.63, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| March 02, 2022 Filed Mar 3, 2022 21:22 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | SaleClass A Common Stock | 2,500 | $45.86 | $114,650.00 |
DisclosureSEC source: 0001062993-22-006655 · form4.xml · nonDerivative · entry 2 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,880 F1 · shares: Sale pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.24 to $46.18, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| March 02, 2022 Filed Mar 3, 2022 21:22 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionClass A Common Stock | 3,423 | $30.63 | $104,846.49 |
DisclosureSEC source: 0001062993-22-006655 · form4.xml · nonDerivative · entry 1 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,380 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2022 Filed Mar 1, 2022 22:58 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 28,577 | $0.00 Strike: $30.63 | $0.00 |
DisclosureSEC source: 0001062993-22-006173 · form4.xml · derivative · entry 6 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,023 Underlying: Class A Common Stock · 28,577 shares Expires 2023-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Currently exercisable in full. Read SEC document |
| March 01, 2022 Filed Mar 1, 2022 22:58 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | SaleClass A Common Stock | 297 | $46.04 | $13,673.88 |
DisclosureSEC source: 0001062993-22-006173 · form4.xml · nonDerivative · entry 4 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,957 F1 · shares: Sale pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.01 to $46.08, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| March 01, 2022 Filed Mar 1, 2022 22:58 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | SaleClass A Common Stock | 28,280 | $45.21 | $1,278,538.80 |
DisclosureSEC source: 0001062993-22-006173 · form4.xml · nonDerivative · entry 3 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,254 F1 · shares: Sale pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.99, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| March 01, 2022 Filed Mar 1, 2022 22:58 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionClass A Common Stock | 28,577 | $30.63 | $875,313.51 |
DisclosureSEC source: 0001062993-22-006173 · form4.xml · nonDerivative · entry 2 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,534 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 22:58 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | GrantClass A Common Stock | 6,744 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-006173 · form4.xml · nonDerivative · entry 1 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,957 Read SEC document |
| February 15, 2022 Filed Feb 18, 2022 02:39 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Tax withholdingClass A Common Stock | 1,729 | $49.65 | $85,844.85 |
DisclosureSEC source: 0001062993-22-004842 · form4.xml · nonDerivative · entry 1 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,213 F1 · shares: Shares withheld to cover tax withholding obligations related to the vesting of previously granted restricted stock units. Read SEC document |
| February 11, 2022 Filed Feb 15, 2022 21:41 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | GrantEmployee Stock Option (Right to Buy) · Derivative | 10,840 | $0.00 Strike: $48.81 | $0.00 |
DisclosureSEC source: 0001062993-22-004463 · form4.xml · derivative · entry 2 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,840 Underlying: Class A Common Stock · 10,840 shares Expires 2028-02-15 F2 · shares: On February 15, 2021, the reporting person was granted stock options to purchase shares of Class A Common Stock, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 11, 2022, the performance criteria were met, resulting in the amount shown above becoming eligible for vesting. Read SEC document |
| February 11, 2022 Filed Feb 15, 2022 21:41 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | GrantEmployee Stock Option (Right to Buy) · Derivative | 33,060 | $0.00 Strike: $30.45 | $0.00 |
DisclosureSEC source: 0001062993-22-004463 · form4.xml · derivative · entry 1 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,118 Underlying: Class A Common Stock · 33,060 shares Expires 2027-02-15 F1 · shares: On February 15, 2020, the reporting person was granted stock options to purchase shares of Class A Common Stock, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 11, 2022, the performance criteria were met, resulting in the vesting of the amount shown above. Read SEC document |
| September 13, 2021 Filed Sep 13, 2021 21:50 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 16,000 | $0.00 Strike: $30.63 | $0.00 |
DisclosureSEC source: 0001062993-21-008532 · form4.xml · derivative · entry 4 CHANG JOSEPH Y · CIK 0001184201 · EVP, Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,600 Underlying: Class A Common Stock · 16,000 shares Expires 2023-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Currently exercisable in full. Read SEC document |
| September 13, 2021 Filed Sep 13, 2021 21:50 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | SaleClass A Common Stock | 16,000 | $47.41 | $758,560.00 |
DisclosureSEC source: 0001062993-21-008532 · form4.xml · nonDerivative · entry 2 CHANG JOSEPH Y · CIK 0001184201 · EVP, Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,942 F1 · shares: Sale pursuant to a Rule 10b5-1 plan adopted by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.15 to $47.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| September 13, 2021 Filed Sep 13, 2021 21:50 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionClass A Common Stock | 16,000 | $30.63 | $490,080.00 |
DisclosureSEC source: 0001062993-21-008532 · form4.xml · nonDerivative · entry 1 CHANG JOSEPH Y · CIK 0001184201 · EVP, Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,942 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 09, 2021 Filed Mar 10, 2021 22:10 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | SaleClass A Common Stock | 626 | $51.55 | $32,270.30 |
DisclosureSEC source: 0001021561-21-000063 · edgar.xml · nonDerivative · entry 1 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,942 F1 · shares: Sale pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $51.52 to $51.56, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| March 04, 2021 Filed Mar 9, 2021 00:53 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Tax withholdingClass A Common Stock | 499 | $49.68 | $24,790.32 |
DisclosureSEC source: 0001021561-21-000055 · edgar.xml · nonDerivative · entry 1 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,568 F1 · shares: Shares withheld to cover tax withholding obligations related to the vesting of previously granted restricted stock units. Read SEC document |
| February 18, 2021 Filed Feb 18, 2021 23:31 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | SaleClass A Common Stock | 1,125 | $49.77 | $55,991.25 |
DisclosureSEC source: 0001021561-21-000042 · edgar.xml · nonDerivative · entry 1 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,067 F1 · shares: Sale pursuant to a Rule 10b5-1 plan adopted by the Reporting Person. Read SEC document |
| February 15, 2021 Filed Feb 17, 2021 22:04 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Tax withholdingClass A Common Stock | 1,179 | $48.81 | $57,546.99 |
DisclosureSEC source: 0001021561-21-000034 · edgar.xml · nonDerivative · entry 2 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,192 F1 · shares: Shares withheld to cover tax withholding obligations related to the vesting of previously granted restricted stock units. Read SEC document |
| February 15, 2021 Filed Feb 17, 2021 22:04 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | GrantClass A Common Stock | 6,557 | $0.00 | $0.00 |
DisclosureSEC source: 0001021561-21-000034 · edgar.xml · nonDerivative · entry 1 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,371 Read SEC document |
| February 10, 2021 Filed Feb 11, 2021 23:08 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | GrantEmployee Stock Option (Right to Buy) · Derivative | 33,058 | $0.00 Strike: $30.45 | $0.00 |
DisclosureSEC source: 0001021561-21-000024 · edgar.xml · derivative · entry 1 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,058 Underlying: Class A Common Stock · 33,058 shares Expires 2027-02-15 F1 · shares: On February 15, 2020, the reporting person was granted stock options to purchase shares of Class A Common Stock, the vesting of which was contingent on Nu Skin Enterprises, Inc.'s satisfaction of certain performance criteria. On February 10, 2021, the performance criteria were met, resulting in the amount shown above becoming eligible for vesting. Read SEC document |
| September 10, 2020 Filed Sep 10, 2020 23:15 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,761 | $0.00 Strike: $39.51 | $0.00 |
DisclosureSEC source: 0001021561-20-000059 · edgar.xml · derivative · entry 10 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: Not disclosed Underlying: Class A Common Stock · 1,761 shares Expires 2021-12-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Currently exercisable in full. Read SEC document |
| September 10, 2020 Filed Sep 10, 2020 23:15 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | SaleClass A Common Stock | 1,561 | $51.48 | $80,360.28 |
DisclosureSEC source: 0001021561-20-000059 · edgar.xml · nonDerivative · entry 7 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,814 F3 · shares: Sale pursuant to a Rule 10b5-1 plan adopted by the reporting person. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.24 to $51.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| September 10, 2020 Filed Sep 10, 2020 23:15 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | SaleClass A Common Stock | 5,308 | $50.69 | $269,062.52 |
DisclosureSEC source: 0001021561-20-000059 · edgar.xml · nonDerivative · entry 6 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,375 F3 · shares: Sale pursuant to a Rule 10b5-1 plan adopted by the reporting person. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.22 to $51.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| September 10, 2020 Filed Sep 10, 2020 23:15 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionClass A Common Stock | 1,761 | $39.51 | $69,577.11 |
DisclosureSEC source: 0001021561-20-000059 · edgar.xml · nonDerivative · entry 5 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,683 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 09, 2020 Filed Sep 10, 2020 23:15 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 5,039 | $0.00 Strike: $39.51 | $0.00 |
DisclosureSEC source: 0001021561-20-000059 · edgar.xml · derivative · entry 9 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,761 Underlying: Class A Common Stock · 5,039 shares Expires 2021-12-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Currently exercisable in full. Read SEC document |
| September 09, 2020 Filed Sep 10, 2020 23:15 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | SaleClass A Common Stock | 9,931 | $49.92 | $495,755.52 |
DisclosureSEC source: 0001021561-20-000059 · edgar.xml · nonDerivative · entry 4 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,922 F3 · shares: Sale pursuant to a Rule 10b5-1 plan adopted by the reporting person. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.88 to $50.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| September 09, 2020 Filed Sep 10, 2020 23:15 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | Exercise / conversionClass A Common Stock | 5,039 | $39.51 | $199,090.89 |
DisclosureSEC source: 0001021561-20-000059 · edgar.xml · nonDerivative · entry 3 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,853 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 23, 2020 Filed Sep 10, 2020 23:15 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | GiftClass A Common Stock | 13,068 | $0.00 | $0.00 |
DisclosureSEC source: 0001021561-20-000059 · edgar.xml · nonDerivative · entry 2 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Indirect · Held in irrevocable family trust Disclosed balance after: 78,068 F1 · kind: The reporting person transferred these shares to an irrevocable family trust for which the reporting person's spouse serves as trustee. The beneficiaries of this trust include the reporting person and certain of his family members. F2 · balance_after: This report should not be deemed an admission that the reporting person is the beneficial owner of such securities for purpose of Section 16 or for any other purpose. Read SEC document |
| June 23, 2020 Filed Sep 10, 2020 23:15 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | GiftClass A Common Stock | 13,068 | $0.00 | $0.00 |
DisclosureSEC source: 0001021561-20-000059 · edgar.xml · nonDerivative · entry 1 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,814 F1 · kind: The reporting person transferred these shares to an irrevocable family trust for which the reporting person's spouse serves as trustee. The beneficiaries of this trust include the reporting person and certain of his family members. Read SEC document |
| June 05, 2020 Filed Jun 8, 2020 23:12 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | SaleClass A Common Stock | 34,970 | $40.01 | $1,399,149.70 |
DisclosureSEC source: 0001021561-20-000053 · edgar.xml · nonDerivative · entry 1 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,882 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.88 to $40.27, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| June 03, 2020 Filed Jun 4, 2020 21:01 UTC | NU SKIN ENTERPRISES, INC. NUS · Entity 6223 | GrantClass A Common Stock | 9,327 | $0.00 | $0.00 |
DisclosureSEC source: 0001021561-20-000047 · edgar.xml · nonDerivative · entry 1 CHANG JOSEPH Y · CIK 0001184201 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,852 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.